pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
1f4c4726-d6a6-425c-9bd1-3d97d5054fc3
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-12 19:57:11
Income (reported)
Expenses (reported)
Expenses method
A
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

STUDENTS FOR SENSIBLE DRUG POLICY

Drug policy reform advocacy

Contact
KAT MURTI
Phone
+1 214-542-4056
Address
zip:20009, city:Washington, state:DC, street:2370 Champlain St NW ste 12

Client

STUDENTS FOR SENSIBLE DRUG POLICY

State
DC
Country
US
Government-entity client
false
Effective date
2021-07-01

Issues lobbied + lobbyists

CIV — Civil Rights/Civil Liberties

STATES 2.0 Act (HR 2934): Issues related state cannabis laws and provisions to enable interstate commerce. PREPARE Act (HR 2935): Issues related to the establishment of a federal commission to design a pathway for full federal cannabis regulation. Evidence-Based Drug Policy Act (HR 3082): Issues related to the authorization of federal agencies to study cannabis legalization and stops requiring the Drug Czar to oppose reform efforts. MORE Act (HR 5068): Issues related to the removal of cannabis from the Controlled Substances Act, expunging certain past convictions, and reinvesting in communities disproportionately harmed by prohibition. The End Needless Distribution of 7-OH Act (H.R. 8000): Issues related to restricting the distribution of synthetic 7-OH products by treating them as a federally controlled substance with no accepted medical use.

Lobbyists: KAT MURTI; GINA GIORGIO

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

VET — Veterans

Veterans Cannabis Use for Safe Healing Act (HR 966): Issues related to the denial of VA benefits to veterans enrolled in state-approved medical cannabis programs and requiring VA providers to discuss and document cannabis use and adjust treatment. Veterans Equal Access Act (HR 1384): Issues related to the authorization of the VA to offer veterans recommendations and opinions regarding participation in their state's respective cannabis programs. Innovative Therapies Centers of Excellence Act of 2025 (HR 2623): Issues related to the designation of at least five VA medical facilities as Innovative Therapies Centers of Excellence.

Lobbyists: KAT MURTI

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.